<DOC>
	<DOCNO>NCT00769873</DOCNO>
	<brief_summary>Splenic/portal vein thrombosis alarm complication splenectomy . Retrospective study literature show incidence symptomatic splenic/portal vein thrombosis 0.7 % ( Rattner et al. , 1993 ) 8 % ( Winslow et al. , 2002 ) . This single-center , prospective , randomize study subject undergo laparoscopic splenectomy . All participant receive one dose pre-operative low molecular weight heparin ( Lovenox® ) subcutaneously , 2 hour prior surgery . Participants randomize pre-operatively treatment control group however treatment allocation reveal surgery complete . Postoperatively , assign treatment group receive 40 mg Lovenox® subcutaneously day 21 day ; control group . Patients severe renal impairment receive adjust dose Lovenox® ( 30 mg subcutaneous dose daily ) . All patient baseline abdominal Doppler ultrasound preoperatively second one do 14 28 day post surgery monitor presence portal vein and/or splenic vein thrombosis . They also lipase liver function test check correlate imaging finding .</brief_summary>
	<brief_title>Anticoagulation Post Laparoscopic Splenectomy</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Scheduled undergo laparoscopic splenectomy The University Alberta Grey Nun 's Community Hospitals Capable understand purpose risk study willing/able sign statement inform consent Willing undergo daily subcutaneous injection Lovenox® Pregnant nursing Unable unwilling provide inform consent Bleeding diathesis currently anticoagulation therapy ( i.e . coumadin , heparin , LMWH ) Hemorrhagic cerebral vascular accident Severe uncontrolled hypertension Diabetic hemorrhagic retinopathy Contradictions anticoagulation ( i.e . active GI bleed , gastric duodenal ulcer , sustain platelet count &lt; 50 x103/uL , splenectomy due trauma history heparin induce thrombocytopenia ) Conversion open splenectomy Allergy Lovenox® , heparin , low molecular weight heparins Bacterial endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>anticoagulation</keyword>
	<keyword>thrombosis</keyword>
	<keyword>portal vein thrombosis</keyword>
	<keyword>splenic vein thrombosis</keyword>
	<keyword>splenectomy</keyword>
	<keyword>randomize</keyword>
	<keyword>laparoscopic splenectomy</keyword>
	<keyword>lovenox</keyword>
</DOC>